I am very sorry to see this happen again to a great company who bent over backwards to assist customers.  I hope ThemoShandonFisherRichardRaymond (to be continued) will start to keep the parts that made Richard Allen, Raymond A. Lamb and others great to work withI am also very sorry to see Tonia and Jerry go.Tuesday, Nov. 11, 2008Thermo Fisher Scientific Strengthens Anatomical Pathology Portfolio withAcquisition of Raymond A. LambWALTHAM, Mass. — Thermo Fisher Scientific Inc., the world leader in servingscience, today announced it has acquired Raymond A. Lamb Ltd., a manufacturer ofhistology and anatomical pathology products based in Eastbourne, U.K., nearLondon.In business since 1964, Raymond A. Lamb has grown to become a global provider ofproducts for the pathology laboratory. Recently, its focus has been on systemsthat automate the labeling and tracking of slides and cassettes that carrypatient tissue samples, reducing the possibility of errors during theirprocessing, storage and retrieval. The company has had a longstandingrelationship with the anatomical pathology business of Thermo Fisher as asupplier of labeling products for cassettes and glass slides, as well as otheranatomical pathology equipment."Our anatomical pathology customers - in both clinical and research markets -are demanding better solutions for tracking the increasing number of samplesthat they need to process and diagnose," said Marijn E. Dekkers, president andchief executive officer of Thermo Fisher Scientific. "This acquisition bringsnew-generation systems that can be integrated with our existing portfolio ofanatomical pathology equipment and consumables to create a more efficient, andreliable, workflow."Raymond A. Lamb had revenues of approximately $9 million in 2007, and will beintegrated into Thermo Fisher's Analytical Technologies Segment.About Thermo Fisher ScientificThermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in servingscience, enabling our customers to make the world healthier, cleaner and safer.With annual revenues of $10 billion, we have more than 30,000 employees andserve over 350,000 customers within pharmaceutical and biotech companies,hospitals and clinical diagnostic labs, universities, research institutions andgovernment agencies, as well as environmental and industrial process controlsettings. Serving customers through two premier brands, Thermo Scientific andFisher Scientific, we help solve analytical challenges from routine testing tocomplex research and discovery. Thermo Scientific offers customers a completerange of high-end analytical instruments as well as laboratory equipment,software, services, consumables and reagents to enable integrated laboratoryworkflow solutions. Fisher Scientific provides a complete portfolio oflaboratory equipment, chemicals, supplies andservices used in healthcare, scientific research, safety and education.Together, we offer the most convenient purchasing options to customers andcontinuously advance our technologies to accelerate the pace of scientificdiscovery, enhance value for customers and fuel growth for shareholders andemployees alike. Visit www.thermofisher.com.AdvertisementThe following constitutes a "Safe Harbor" statement under the Private SecuritiesLitigation Reform Act of 1995: This press release contains forward-lookingstatements that involve a number of risks and uncertainties. Important factorsthat could cause actual results to differ materially from those indicated bysuch forward-looking statements are set forth in the company's Quarterly Reporton Form 10-Q for the quarter ended September 27, 2008, under the caption "RiskFactors," which is on file with the Securities and Exchange Commission (SEC) andavailable in the "Investors" section of our Website under the heading "SECFilings." Important factors that could cause actual results to differ materially=0Afrom those indicated by forward-looking statements include risks anduncertainties relating to: competition and its effect on pricing, spending,=0Athird-party relationships and revenues; the need to develop new products andadapt to significant technologicalchange; implementation of strategies for improving internal growth; generalworldwide economic conditions and related uncertainties; use and protection ofintellectual property; dependence on customers' capital spending policies andgovernment funding policies; realization of potential future savings from newproductivity initiatives; the effect of changes in governmental regulations; theeffect of exchange rate fluctuations on international operations; the effect of=0Alaws and regulations governing government contracts; the effect of competingwith certain of our customers and suppliers; and the effect of rapid changes inthe healthcare industry. While we may elect to update forward-looking statementsat some point in the future, we specifically disclaim any obligation to do so,even if our estimates change and, therefore, you should not rely on theseforward-looking statements as representing our views as of any date subsequentto to      
_______________________________________________
Histonet mailing list
Histonet@lists.utsouthwestern.edu
http://lists.utsouthwestern.edu/mailman/listinfo/histonet